Jisheng Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jisheng Wang has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Jing Chen
Department of Clinical Pharmacy, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan, People’s Republic of China
1 shared publicationJing Li
Department of Neurology, Mianyang people’s Hospital, Mianyang, Sichuan, People’s Republic of China
1 shared publication- Tingrui Zhao
Department of Clinical Pharmacy, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan, People’s Republic of China
1 shared publication
Latest Publications
- Open Access
- 3 July 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (27) , e49670
Comprehensive analysis of factors to consider when using glucocorticoids for sCAP: A review
Severe community-acquired pneumonia (sCAP) is a serious respiratory disease that often requires urgent and comprehensive treatment. The use of glucocorticoids for the treatment of sCAP has been a focus of discussion in the medical community because of their potential benefits and safety concerns. A literature review showed that the benefits of glucocorticoids in the treatment of sCAP may be related to factors such as oxygenation index, high CRP levels, shock, non-influenza, female gender, early application, and hydrocortisone. The application of glucocorticoids in the treatment of sCAP needs to be considered on an individual basis, weighing the potential benefits and risks, and monitoring and preventing possible side effects.
- 3 July 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (27) , e49670
Open AccessComprehensive analysis of factors to consider when using glucocorticoids for sCAP: A review
Severe community-acquired pneumonia (sCAP) is a serious respiratory disease that often requires urgent and comprehensive treatment. The use of glucocorticoids for the treatment of sCAP has been a focus of discussion in the medical community because of their potential benefits and safety concerns. A literature review showed that the benefits of glucocorticoids in the treatment of sCAP may be related to factors such as oxygenation index, high CRP levels, shock, non-influenza, female gender, early application, and hydrocortisone. The application of glucocorticoids in the treatment of sCAP needs to be considered on an individual basis, weighing the potential benefits and risks, and monitoring and preventing possible side effects.